Related Experiment Video
Updated: Jun 17, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
A negative regulatory role for Y1111 on the Tie-2 RTK
1Molecular and Cellular Biology Research, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Abstract:
Tie2 is a receptor tyrosine kinase (RTK) essential for aspects of both normal and pathological angiogenesis. Understanding how this receptor is regulated is important for development of therapeutic angiogenic agents. Evidence suggests the C-terminal tail of the receptor plays a negative regulatory role in Tie2 signaling and function. Here we investigated the role of a specific C-tail residue, Y1111, in Tie2 signaling by generating a number of receptor point mutants. We found that mutation of this site to phenylalanine (Y1111F) results in an increase in receptor phosphorylation and kinase activity, as well as increased downstream signaling. Furthermore, mutation of Y1111 to the highly charged aspartate (Y1111D) or glutamate (Y1111E) results in even more dramatic increase in receptor phosphorylation and activity. Limited protease digestion studies indicate that these mutations may alter receptor conformation and potentially relieve negative inhibition imparted by the C-tail of Tie2. These studies suggest that Y1111 plays a key role in negative regulation of Tie2 activity and they provide important insight into molecular mechanisms behind the intrinsic ability of this RTK to regulate its own activity.
Insights
Investigating the Tie2 receptor tyrosine kinase (RTK), this study reveals that the Y1111 residue in its C-tail is crucial for negative regulation. Mutations at Y1111 enhance Tie2 phosphorylation, kinase activity, and downstream signaling.
Area of Science:
- Molecular biology
- Cell signaling
- Angiogenesis research
Background:
- Tie2 receptor tyrosine kinase (RTK) is vital for angiogenesis, both normal and pathological.
- Understanding Tie2 regulation is key for developing therapeutic angiogenic agents.
- The C-terminal tail of Tie2 is implicated in negative regulation of its signaling.
Purpose of the Study:
- To investigate the role of the C-tail residue Y1111 in Tie2 signaling and regulation.
- To elucidate the molecular mechanisms of Tie2 auto-regulation.
Main Methods:
- Generation of Tie2 receptor point mutants, specifically at the Y1111 site (Y1111F, Y1111D, Y1111E).
- Assays to measure receptor phosphorylation, kinase activity, and downstream signaling.
- Limited protease digestion to study receptor conformation changes.
Main Results:
- Mutation of Y1111 to phenylalanine (Y1111F) increased Tie2 phosphorylation, kinase activity, and downstream signaling.
- Mutation of Y1111 to aspartate (Y1111D) or glutamate (Y1111E) caused a more significant increase in Tie2 phosphorylation and activity.
- Protease digestion suggested mutations alter receptor conformation, potentially relieving C-tail-mediated inhibition.
Conclusions:
- Y1111 is a critical residue for the negative regulation of Tie2 activity.
- These findings offer insights into the intrinsic auto-regulatory mechanisms of Tie2.
- Targeting Y1111 could be a strategy for modulating Tie2 activity in therapeutic contexts.
Related Concept Videos
Negative Regulator Molecules
Receptor Tyrosine Kinases
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
TGF - β Signaling Pathway

